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Background. Interstitial fibroblasts are a minor, but nevertheless very important, component of the kidney. They secrete and
remodel extracellular matrix and they produce active compounds such as erythropoietin. However, studying human renal
fibroblasts has been hampered by the lack of appropriate surface markers. Methods and Findings. The expression of
cadherin-9 in various human renal cell lines and tissues was studied on the mRNA level by RT-PCR and on the protein level with
the help of newly generated cadherin-9 antibodies. The classical type II cadherin-9, so far only described in the neural system,
was identified as a reliable surface marker for renal fibroblasts. Compared to FSP1, a widely-used cytosolic renal fibroblast
marker, cadherin-9 showed a more restricted expression pattern in human kidney. Under pathological conditions, cadherin-9
was expressed in the stroma of renal cell carcinoma, but not in the tumor cells themselves, and in renal fibrosis the percentage
of cadherin-9-positive cells was clearly elevated 3 to 5 times compared to healthy kidney tissue. Induction of epithelial
mesenchymal transition in renal epithelial cells with cyclosporin-A, which causes renal fibrosis as a side effect, induced
cadherin-9 expression. Functional studies following siRNA-mediated knockdown of cadherin-9 revealed that it acts in the
kidney like a typical classical cadherin. It was found to be associated with catenins and to mediate homophilic but not
heterophilic cell interactions. Conclusions. Cadherin-9 represents a novel and reliable cell surface marker for fibroblasts in
healthy and diseased kidneys. Together with the established marker molecules FSP1, CD45 and a smooth muscle actin,
cadherin-9 can now be used to differentiate the heterogenic pool of renal fibroblasts into resident and activated fibroblasts,
immigrated bone marrow derived fibroblast precursors and cells in different stages of epithelial mesenchymal transition.
Citation: Thedieck C, Kalbacher H, Kuczyk M, Mu ¨ller GA, Mu ¨ller CA, et al (2007) Cadherin-9 Is a Novel Cell Surface Marker for the Heterogeneous Pool
of Renal Fibroblasts. PLoS ONE 2(8): e657. doi:10.1371/journal.pone.0000657
INTRODUCTION
The most prominent cell type of the adult kidney is the polarized
epithelial cell, and in the healthy organ only a few spindle-shaped
fibroblasts can be found in the interstitial space between renal
tubules and collecting ducts. Nevertheless, these renal fibroblasts
represent a functionally essential part of the kidney. During
embryonic development, the epithelial tubules are generated from
the metanephric mesenchyme by an inductive process known
as MET-mesenchymal to epithelial transition [1,2]. Embryonic
mesenchymal cells which do not undergo MET can form the cells of
the renal stroma [3], but the heterogeneous renal stromal cells in the
adult kidney, including the interstitial fibroblasts, are not very well
characterized. This is mainly due to the fact that unambiguous
marker molecules for stromal cells are not readily available. So far,
the most intensively characterized renal fibroblast marker is FSP1,
fibroblast-specific protein 1 [4], but it has the disadvantage that it
might also be expressed by macrophages and monocytes, as
currently discussed [5]. Functionally, renal fibroblast-like cells are
proposed to play a role in tissue regeneration [6], and are also
responsible for extracellular matrix secretion and erythropoietin
production [7–9]. Under pathological conditions during renal
fibrosis, increased numbers of renal fibroblasts can be observed.
Tubulo-interstitial fibrosis, which is regarded as the common final
pathway of end-stage renal disease, is characterized by the
accumulation of extracellular matrix deposited by the renal
fibroblasts [10,11]. Emerging evidence suggests that the disease-
related fibroblasts originate from tubular epithelial cells in a process
dubbed EMT-epithelial to mesenchymal transition [12–14].
Little is known about the role of cadherins in mesenchymal cells
of the kidney. The cadherins constitute a large gene family of
multifunctional cell adhesion receptors which play pivotal roles not
only in embryonic development, but also in the maintenance of
tissue architecture [15–17]. Cadherins mainly mediate Ca
2+-
dependent homophilic cell-cell interactions, but they can also be
involved in signal transduction processes [18,19]. Based on their
structural and functional organization, cadherins are subdivided
into different subfamilies, the most intensively studied being the
classical type I and II cadherins [20,21]. In the human kidney,
a complex pattern of cadherin expression is seen. Epithelial cells of
the proximal tubules express N-cadherin and cadherin-6 (K-
cadherin), whereas in distal tubules, E-cadherin and cadherin-16
(Ksp-cadherin) are present [22–25]. R-cadherin and cadherin-8
seem to play a role in the differentiating metanephric mesenchyme
only during kidney development [26–28]. So far, human cadherin-
9, a classical type II cadherin, has only been described in the brain
[29], but an RT-PCR screening of renal cells and tissues for
classical type II cadherins indicated cadherin-9 as a stromal
cadherin of the human kidney.
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PLoS ONE | www.plosone.org 1 August 2007 | Issue 8 | e657In the present study, therefore, we analyzed in detail the
expression pattern of cadherin-9 in the developing and adult
human kidney. Expression of cadherin-9 was also studied under
pathological conditions in renal fibrosis and renal cell carcinoma,
as well as in chemically induced epithelial-mesenchymal transition.
Because cadherin-9 was found to be exclusively expressed by renal
fibroblasts, its expression pattern was used, in combination with
other stromal cell markers, to differentiate between the heteroge-
neous fibroblast subpopulations in the human kidney. The
functional activity of cadherin-9 on renal mesenchymal cells was
analyzed in cell adhesion and migration assays.
MATERIALS AND METHODS
Renal cell lines and tissues
All cell lines used were cultured in RPMI-1640 with glutamine and
25 mM HEPES (PAA, Coelbe, Germany) supplemented with 10%
FCS. The renal fibroblast cell lines TK 173 and TK 188 as well as
the renal epithelial cell line TK 163 have been described earlier
[30]. The RCC cell lines used were those described recently [25].
Biopsies of fibrotic kidneys were taken for diagnostic reasons.
Fibrotic tissues and fibroblast cell lines with the corresponding
histopathology are listed in Table 1. Specimens of RCC tissues
and the surrounding, histologically normal kidney tissues were
obtained after informed written consent from RCC patients at the
time of surgery. In addition, an unaffected normal kidney was also
used. All tissue samples were immediately snap frozen in liquid
nitrogen. The study was approved by the local ethics committees
of the universities of Tu ¨bingen and Go ¨ttingen. Total RNAs of
embryonic kidneys from pregnancy weeks 6, 9 and 12 were
received from ViroGen (Watertown, MA).
Reverse transcriptase polymerase chain reaction
(RT-PCR)
RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden,
Germany). The FirstChoice
H Human Total RNA Survey Panel
was obtained from Ambion (Huntingdon, UK). RT-PCR was
performed using the SuperScript
TM One-Step RT-PCR with
Platinum
H Taq (Invitrogen, Karlsruhe, Germany). Primers for
cadherin-9 were designed according to the sequence NM_016279
(GenBank): cadherin-9 forward 59-GCAAGCTTCACACTGAC-
CAA, cadherin-9 reverse 59-ATCGAGGAGGGTTGTTGTTG.
Antibodies
Cadherin-9 antisera were produced using a peptide representing
a cadherin-9 sequence (Swiss-Prot: Q9ULB4) with a high antigenic
index. The specificity of the peptide was confirmed by a BLAST
search. Two rabbits were immunized. The antiserum of the first
rabbit performed well in immunohistochemistry and was affinity
purified using the antigenic peptide. The antiserum of the second
rabbitwasIgG-purifiedandemployedforWesternblotanalysis.The
specificity of both antisera was verified in an ELISA using the
antigenic peptide. All other antibodies used are listed in Table 2.
Immunohistochemistry and immunofluorescence
staining
The Envision method (DAKO) was applied to detect cadherin-9 in
tissue sections mounted in Entellan (Merck). Immunohistochem-
ical images were taken using a Leitz DM-RBE microscope (Leica)
with 206/0.5 and 406/0.7 objectives at room temperature and
the Leica QWin software. For immunofluorescence staining, 5 mm
tissue cryostat sections and cells grown in BD Falcon
TM
CultureSlides (Heidelberg, Germany) were used. After fixation,
non-specific binding sites were blocked with 3.75% BSA in TNC
(10 mM Tris pH 7.4, 150 mM NaCl, 2 mM CaCl2). The primary
antibody diluted in blocking solution was applied for one hour,
except E-cadherin which was stained overnight at 4uC. After
washing in TNC, sections were incubated with Cy3- or FITC-
labeled secondary antibodies diluted in blocking solution for one
hour. Cell nuclei were visualized by counterstaining with DAPI.
Control staining was performed by omitting the primary antibody.
All labeled sections were mounted in Mowiol embedding medium.
Fluorescent images were visualized using an inverted microscope
(Zeiss Axiophot) with 206/0.50 and 406/0.75 objectives at room
temperature and captured using AnalySIS DOKU
H software (Soft
Table 1. Histopathologies of fibrosis patients and the
corresponding tissues of renal fibroblast cell lines.
......................................................................
sex/age* diagnosis
fibrosis patient A m/55 not known
fibrosis patient B f/47 acute glomerulonephritis, interstitial
nephritis
fibrosis patient C m/30 acute interstitial nephritis,
glomerulonephritis
fibrosis patient D m/48 mesangioproliferative glomerulonephritis
fibrosis patient E m/72 mesangioproliferative glomerulonephritis
cell line TK 173 m/4 nephrotic syndrome, without fibrosis
cell line TK 188 f/55 IgA nephritis, renal fibrosis
*at time of diagnosis
doi:10.1371/journal.pone.0000657.t001
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Table 2. Sources of the used antibodies
......................................................................
antibody Source
anti FSP1/S100A4 Ab-8 Dianova (Hamburg, Germany)
anti E-cadherin (clone HECD-1) TaKaRa (Otsu, Japan)
anti cadherin-6 (clone 2B6) Acris antibodies (Hiddenhausen,
Germany)
anti Ksp-cadherin (clone 4H6/F9) Zymed Laboratories (San Francisco,
CA)
anti aV-integrin (clone SAM-2) Zymed Laboratories
anti b-catenin (clone 14) BD Transduction Laboratories
(Heidelberg, Germany)
anti a-smooth muscle actin (clone 1A4) Sigma (Taufkirchen, Germany)
anti vimentin (clone V9) Sigma
anti c-catenin (clone 15F11) Sigma
anti CD31 (clone Rb10) kind gift from Rupert Hallmann
(University of Mu ¨nster, Germany)
anti CD45 (clone TL-1) Leukocyte Typing IV, Workshop no.
N818 (31)
Cy3
TM-coupled goat anti rabbit Dianova
FITC-coupled goat anti mouse Dianova
alkaline phosphatase-conjugated
goat anti rabbit
Dianova
alkaline phosphatase-conjugated rabbit
anti mouse
DAKO (Hamburg, Germany)
doi:10.1371/journal.pone.0000657.t002
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PLoS ONE | www.plosone.org 2 August 2007 | Issue 8 | e657Imaging System Corp.). All images were prepared using Photo-
Impact
H XL (ULEAD) software.
Immunoblot analysis and immunoprecipitation
Cells were lysed with RIPA (50 mM Tris pH 7.4, 150 mM NaCl,
1 mM EDTA, 1% Triton X-100, 1% sodium deoxycholate, 0.1%
SDS and proteinase inhibitors) and tissues with 0.6% CHAPS in
PBS containing protease inhibitors. 8 or 12% minigels (Bio-Rad,
Munich, Germany) were run at 40mA per gel. After transfer and
blocking with 5% skimmed milk in TBS, the primary antibody
diluted in blocking solution was applied for 2 hours at 37uC. After
washingwithTTBS(TBSwith0.05%Tween20)themembranewas
incubated with the appropriate alkaline phosphatase-conjugated
secondary antibody. The blots were developed with BCIP/NBT (5-
Bromo-4-chloro-3-indolylphosphate/Nitro blue tetrazolium, Sig-
ma). For immunoprecipitations, antibodies were coupled to Pro-
tein-A agarose (Sigma). Simultaneously, non-specifically binding
proteins were removed from kidney tissue lysates by pre-clearing.
After antibody coupling, the beads were washed with PBS and then
incubated for 1 hour at 4uC with the pre-cleared kidney lysate. The
pellets were washed, resuspended in sample loading buffer,
denatured for 5 minutes at 95uC and used for Western blotting.
Blocking of cadherin-9 antibody with the antigenic
peptide
To prove the specificity of the cadherin-9 antibodies in Western
blotting and immunofluorescence staining, the diluted antibody
was pre-incubated with 20 mg/ml for Western blotting or 40 mg/
ml for immunofluorescence staining of the cadherin-9 peptide-
ovalbumin conjugate containing the antigenic peptide. As
a positive control, the antiserum was pre-incubated without the
antigenic peptide-conjugate.
Downregulation of cadherin-9 by siRNA treatment
TK 188 cells were transfected with two cadherin-9-specific
siRNAs HP from Qiagen. TK 188 cells were trypsinized for
15 minutes and 5610
5 cells were seeded in 4 ml medium. 5 nM of
each cadherin-9-specific siRNA and 20 ml HiPerfect (Qiagen) in
100 ml serum free medium were incubated for 10 minutes at RT
and added drop-wise to the cells. As a negative control, cells were
transfected with 10 nM of non-silencing control siRNA. The cells
were incubated for 48 hours at 37uC and then used in functional
assays. The silencing effect was monitored by Western blotting.
Induction of EMT by cyclosporin-A
TK 163 cells were seeded in BD Falcon
TM CultureSlides and
grown for 24 hours. Cells were washed with PBS and incubated
without or with 4.2 mMo r4 2mM cyclosporin-A (Calbiochem,
Darmstadt, Germany) in serum-free culture medium for 48h.
Aggregation assay
siRNA-treated TK 188 cells were harvested with 0.02% trypsin,
20 mM CaCl2 in HBSS. Cells were resuspended in assay buffer
(1% BSA, 1 mM CaCl2, 0.1 mg/ml DNaseI in HBSS). 1610
5
cells/200 ml were transferred to a 48-well plate which was blocked
with 2% BSA/PBS. Cell aggregation was performed at 37uC and
225 rpm. Cells were fixed at the beginning (t=0) and after
20 minutes of aggregation with 2.5% glutaraldehyde. Aggregation
was quantified by counting particles in a Neubauer chamber. To
obtain statistically significant particle numbers, at least three
Neubauer chambers were counted per well. The number of
particles at t=0 was set as 100%.
Statistical analysis
Experimental data of the aggregation assay were analyzed by a two-
sided modified Student’s t-test and a p-value of data sets equal or
lower than 0.001 was considered to be statistically significant.
RESULTS
Cadherin-9 expression in human kidney
Initial RT-PCR screening of classical type II cadherin expression
in renal tissue had revealed that the mRNA for cadherin-9 was
transcribed in the adult human kidney. To study the general tissue
distribution of cadherin-9 in humans, a tissue RNA-panel was
screened by RT-PCR. In addition to the brain, where human
cadherin-9 was originally described [29], the highest expression
was observed in kidney. Weaker signals for cadherin-9 expression
were found in testes, colon, small intestine and adipose tissue
(Fig. 1, Fig. S1). During embryonic kidney development, cadherin-
9 expression was already detectable at the 6
th week of gestation
(Fig. 2A). Strong signals were also obtained at later embryonic
stages and in the adult organ. In contrast to human kidney,
cadherin-9 was no longer present at the end of embryonic kidney
development in the mouse, and was not detectable in the adult
kidney (data not shown).
To specifically detect cadherin-9 at the protein level, two anti-
cadherin-9 antisera were produced. Because cadherin-9 is highly
homologous to two other type II cadherins, cadherin-6 and –10,
the only cadherin-9-specific peptide sequence with an acceptable
antigenic index was found to be located in the cytoplasmic domain
from amino acid 701 to 719. A ClustalW alignment of the classical
cadherin family confirmed the specificity of the chosen peptide for
cadherin-9 (Table 3). Only single amino acids of this peptide are
conserved in the other cadherins closely related to cadherin-9. The
specificity of the affinity-purified antibodies was verified by
blocking with the antigenic peptide using different methods
(Fig. 2C, 4A) and by ELISA. A cross reaction of the antisera
with the close relatives cadherin-6 or -10 could be excluded, since
the antisera did not give positive signals with RCC-cell lines, some
of which are positive for the latter cadherins, or cadherin-6-
positive renal epithelia.
Several human kidney cell lines were analyzed for cadherin-9
expression on the mRNA and protein levels. The only cell line
Figure 1. Tissue distribution of cadherin-9. An RT-PCR analysis of
a human tissue RNA panel revealed that, apart from the brain, the
strongest cadherin-9 expression can be detected in the kidney. Weaker
signals could be found in testes (where cadherin-9 was originally
described in mice), adipose tissue, colon and small intestine.
doi:10.1371/journal.pone.0000657.g001
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fibroblast cell line TK 188, which was generated from a fibrotic
kidney. In contrast, the renal fibroblast cell line TK 173, derived
from a non-fibrotic kidney, and the renal epithelial cell line TK
163 were negative for cadherin-9 expression (Fig. 2B). Endothelial
cells (e.g., HUVEC) do not express cadherin-9 (data not shown).
In normal human kidneys, cadherin-9 expression was found to
be restricted to single interstitial cells located between renal tubules
or outlining the border of the Bowman’s capsule. No expression
was detectable in tubular epithelial cells or in glomeruli (Fig. 3).
These results suggest that cadherin-9 might be exclusively
expressed by renal fibroblasts.
Cellular localization and function
At the cellular level, cadherin-9 expression was quite evenly
distributed over the entire cell surface of the renal fibroblast cell
line TK 188 (Fig. 4A). It does not seem to be concentrated at cell-
cell contacts nor in focal adhesions which were marked by aV
integrin. After fixation with acetone, we could not exclude with
certainty that cadherin-9 might also be located in the cytoplasm.
Therefore, TK 188 cells were treated with trypsin in the presence
of EDTA, which is able to degrade cadherins (Fig. 4B). Already
after 10 minutes of trypsin digest, the intact full length cadherin-9
disappeared in Western blots, demonstrating its localization on the
cell surface. At the same time a fragment of approximately 26 kDa
appeared, which most likely represented the C-terminal part of
cadherin-9 including the cytosolic domain, a part of the molecule
not accessible to trypsin digestion. After permeabilization of the
cell membrane with Triton X-100, the 26 kDa fragment was no
longer detectable.
Co-immunoprecipitation of cadherin-9 with b- and c-catenin in
normal human kidney lysates was performed to analyze direct
interactions of cadherin-9 with cytosolic catenins, a typical feature
of type I and II cadherins. After precipitation with b-o rc-catenin-
specific antibodies, cadherin-9 was detectable in Western blot
analysis, demonstrating its physical association with both catenins
(Fig. 4C).
Cadherin-9seemsto playaroleincell-cellinteractionasshownby
a cell aggregation assay (Fig. 4D). Cadherin-9 expression was down-
regulated in TK 188 cells by siRNA treatment. The efficiency of the
siRNA knockdown was evaluated by Western blot analysis.
Cadherin-9 expression was completely abrogated after treatment
with the specific siRNA. Compared to cells treated with control
siRNA, the ability of the cadherin-9-deficient cells to aggregate was
significantly impaired (Fig. 4D, Fig. S2). In transmigration and
wound closure experiments, however, knockdown of cadherin-9 had
no significant effects (data not shown). Therefore, cadherin-9 does not
seem to influence cell migration, but, despite its atypical distribution
over the entire cell surface, nonetheless displays typical features of
classical cadherins, namely, interactions with cytosolic catenins and
involvement in cell-cell aggregation.
Cadherin-9 expression is not locally associated with
E- or Ksp-cadherins or cadherin-6
Because the cadherin family shows a complex expression pattern
in the human kidney, the localization of cadherin-9 in relation to
the epithelial E- and Ksp-cadherins and cadherin-6 was analysed
by double immunofluorescence staining. In an in vitro assay,
cadherin-9 mediated homophilic interactions, but it could also
bind to cadherin-6 and -10 ina heterophilic manner [29]. Cadherin-
6 but not -10 is expressed in the adult human kidney (data not shown).
Double labeling with cadherin-6, which is expressed by proximal
tubular epithelial cells, did not reveal any obvious co-localization
(Fig.5),suggesting thatinvivo in the kidney tissue cadherin-9 does not
interactwithcadherin-6,althoughtheyareabletobindtoeachother
in vitro. Kidney specimens were also stained for E- or Ksp-cadherin,
which both mark the distal tubules of the human kidney (Fig. 5).
Single cadherin-9-positive cells were localized between the distal
tubules. No obvious preference for cadherin-9 expression near
proximal or distal tubules was observed.
Cadherin-9 in diseased kidneys
The expression pattern of cadherin-9 was also studied under two
pathological conditions, renal cell carcinoma and renal fibrosis. In
renal tumor tissue, the amount of cadherin-9, compared to the
corresponding normal kidney tissue, is considerably lower as
Figure 2. Cadherin-9 appears early in human kidney development
and is expressed by a renal fibroblast cell line. (A) During human renal
organogenesis, cadherin-9 mRNA is already detectable in the 6
th week
of gestation. Positive signals were found throughout embryonic
development and in the adult kidney. (B) RT-PCR screening of human
renal cell lines detected cadherin-9 only in the renal fibroblast line TK
188 which was generated from a fibrotic kidney. Cadherin-9 was neither
found in the fibroblast line TK 173 which originates from a normal
kidney nor in the renal epithelial cell line TK 163. (C) These results were
confirmed by Western blotting with a polyclonal anti-cadherin-9
antibody. The specificity of the anti-cadherin-9 antiserum was shown
by pre-incubation of the antiserum with the peptide which the
antibody was raised against (nb=non-blocked; b=blocked with
peptide).
doi:10.1371/journal.pone.0000657.g002
Cadherin-9 Kidney Fibroblasts
PLoS ONE | www.plosone.org 4 August 2007 | Issue 8 | e657shown by RT-PCR and Western blot analysis (Fig. 6C,D). All
RCC cell lines tested were negative for cadherin-9 on the mRNA
and protein levels (Fig. 6A,B). This result is a strong indication that
in renal tumor tissues cadherin-9 is also not expressed by the
tumor cells, which are of epithelial origin, but by the stromal cells
within the tumor. Immunohistochemical staining of several tumor
tissues confirmed this notion. Cadherin-9-positive cells in renal cell
carcinomas display an elongated and even spindle-shaped stromal
cell phenotype (Fig. 6E). Thus, as in healthy kidneys, cadherin-9 in
renal tumors is restricted to stromal cells and cannot be found on
epithelial cells.
In renal fibrotic tissues the amount of cadherin-9 positive cells
seems to be higher compared to normal kidneys (Fig. 7 and Fig. 3).
Expression was quantified independently by three different
Table 3. ClustalW-alignment of cadherin family members and the cadherin-9 antigenic peptide.
..................................................................................................................................................
Gene Sequence Aminoacid No.
CADH1_HUMAN R-NDVAPTLMSVPRYLPRPANPDEIGNFIDENLKAADTDPTAPPYDSLLVFDYEGSGSEA 842
CADH3_HUMAN LRNDVAPTIIPTPMYRPRPANPDEIGNFIIENLKAANTDPTAPPYDTLLVFDYEGSGSDA 789
CADH2_HUMAN RMDERPIHAEPQYPVRSAAPHPGDIGDFINEGLKAADNDPTAPPYDSLLVFDYEGSGSTA 867
CADH4_HUMAN RVDERPVGAEPQYPIRPMVPHPGDIGDFINEGLRAADNDPTAPPYDSLLVFDYEGSGSTA 877
CADH5_HUMAN RPSLYAQVQKPPRHAPGAHGGPGEMAAMIEVKKDEADHDGDGPPYDTLHIYGYEGSESIA 740
CADH6_HUMAN RRDIVPEALFLPRRTPT-ARDNTDVRDFINQRLKENDTDPTAPPYDSLATYAYEGTGSVA 747
CADH7_HUMAN RRDVTPEIQFLSRPAFKSIPDNVIFREFIWERLKEADVDPGAPPYDSLQTYAFEGNGSVA 742
CADH8_HUMAN RKDIKPDLQFMPRQGLAPVPNGVDVDEFINVRLHEADNDPTAPPYDSIQIYGYEGRGSVA 756
CADH9_HUMAN RRDVMPETIFQIRRTVP-LWENIDVQDFIHRRLKENDADPSAPPYDSLATYAYEGNDSIA 747
CAD10_HUMAN RRDIIPETLFIPRRTPT-APDNTDVRDFINERLKEHDLDPTAPPYDSLATYAYEGNDSIA 745
CAD11_HUMAN RKDIKPEYQYMPRPGLRPAPNSVDVDDFINTRIQEADNDPTAPPYDSIQIYGYEGRGSVA 752
CAD12_HUMAN RRDIKPDSLCLPRQRPP-MEDNTDIRDFIHQRLQENDVDPTAPPIDSLATYAYEGSGSVA 748
CAD13_HUMAN ------------------------------------------------------------
CAD15_HUMAN LRRDAPQGRLHPQPPRVLPTSPLDIADFINDGLEAADSDPSVPPYDTALIYDYEGDGSVA 746
CAD16_HUMAN GLIVSGPSKDPDLASGHGPYSFTLGPNPTVQRDWRLQTLNGSHAYLTLALHWVEPREHII 742
CAD17_HUMAN HLFRGPHFTFSLGSGSLQNDWEVSKINGTHARLSTRHTDFEERAYVVLIRINDGGRPPLE 755
CAD18_HUMAN RRDIRPEVKLTPRHQTSSTLESIDVQEFIKQRLAEADLDPSVPPYDSLQTYAYEGQRSEA 747
CAD19_HUMAN RKTTSAEIRSLYRQSLQVGPDSAIFRKFILEKLEEANTDPCAPPFDSLQTYAFEGTGSLA 730
CAD20_HUMAN RQDMLPEIESLFRYVPQTCAVNSTVHSYVLAKLYEADMDLWTPPFDSLQTYMFEGDGPVA 757
CAD22_HUMAN QAHLPSERHSLPQGPPSPEPDFSVFRDFISRKVALADGDLSVPPYDAFQTYAFEGADSPA 782
CAD23_HUMAN LLMRGPRPLDRERNSSHVLIVEAYNHDLGPMRSSVRVIVYVEDINDEAPVFTQQQYSRLG 1217
CAD24_HUMAN PPARRDVLPRARVSRQPRPPGPADVAQLLALRLREADEDPGVPPYDSVQVYGYEGRGSSC 775
CAD26_HUMAN LAPVEGRMAETLNQSKERNRFSLSRGCIIPQGRATAGRGLPQDIYKEMMPRRLTQTGKRK 765
Bold letters mark the peptide, which was used for the generation of the cadherin-9 specific antiserum and the matching amino acids in the other cadherin-family
members. There are only few conserved amino acids, especially in the cadherin-6 and -10 sequences.
doi:10.1371/journal.pone.0000657.t003
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Figure 3. Renal interstitial cells located between tubuli or at the border of glomeruli express cadherin-9. Cadherin-9-positive cells were identified
by immunohistochemical staining with the affinity-purified anti-cadherin-9 polyclonal antibody. The sections were counterstained with hematoxylin-
eosin. Arrows point to some of the cadherin-9 expressing cells. Panel B shows a part of A in a higher magnification. Bars: (A) 50 mm, (B) 20 mm.
doi:10.1371/journal.pone.0000657.g003
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PLoS ONE | www.plosone.org 5 August 2007 | Issue 8 | e657Figure 4. Cellular localization and functional involvement in fibroblast cell aggregation. (A) Immunofluorescence staining of cadherin-9 labeled the
whole cell surface of TK 188 cells, and not, as initially expected, only cell-cell contacts. The specificity of the staining was shown by blocking with the
antigenic peptide. In double staining experiments, the integrin av-chain which marks focal adhesions showed no co-localization with cadherin-9. Bars,
50 mm. The pictures of the blocking experiment and the double-staining were gamma-corrected (B) To verify the expression on the cell surface, cellular
cadherins were digested with trypsin in the presence of EDTA and subjected to Western blotting. After 10 minutes already, no full length cadherin-9
product was detectable, whereas a digestion fragment of approximately 26 kDa appeared. This fragment is most likely the C-terminal end containing the
cytoplasmic tail, the transmembrane domain and a radically truncated extracellular domain. This fragment is protected from digestion in the absenceo f
Triton X-100 and can be recognized by the antibody. In the presence of Triton X-100 no cadherin-9 signals were visible. The control cells which were not
trypsin-treated showed the full length cadherin-9 product. (C) Co-immunoprecipitation experiments demonstrated the interaction of cadherin-9 with b-
and c-catenin. The pictures of the different immunoblots were gamma-corrected. (D) Cadherin-9 was knocked-down in TK 188 cells by siRNA, and the
efficiency of the down-regulation after two days of incubation was shown by Western blotting (on the right). The siRNA treated cells were used for an
aggregation assay. The diagram summarizes the data collected in four independent experiments, each of them showing similar results. The capacity to
form aggregates was significantly diminished (p,0.00001) in cadherin-9 siRNA-treated cells, since these cells showed, after 30 minutes of aggregation,
only 25.2% of their initial number of particles, whereas control siRNA-treated cells showed 13.6%. Error bars indicate the error of the mean.
doi:10.1371/journal.pone.0000657.g004
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cadherin-9 positive cells in representative microscopic view fields.
The percentage of cadherin-9-expressing cells was three to five
times higher in kidney specimens from fibrosis patients than in
healthy kidneys. In fibrotic renal tissue, up to 42.5%61.1 of the
cells displayed cadherin-9, whereas in a healthy kidney only
8.4%61.8 of the cells expressed this molecule. Because the
number of fibroblasts can be greatly elevated in fibrotic tissues, this
finding substantiated our theory that the cell type expressing
cadherin-9 in the human kidney is indeed the renal fibroblast.
Presence of cadherin-9 on defined subpopulations
of renal fibroblasts
FSP1 is one of the best described markers for human renal
fibroblasts [4]. Immunohistochemical staining of consecutive
sections of human normal kidney specimens revealed that
cadherin-9-positive cells also expressed FSP1 (Fig. 8A), although
there were many more FSP1-positive than cadherin-9-positive
cells. These FSP1-positive cadherin-9-negative cells were observed
in the interstitium, in glomeruli and intercalating within the
tubules. Thus, cadherin-9 expression seems to be more restricted
than FSP1.
Cadherin-9 was not expressed by endothelial cells as demon-
strated by double staining with the endothelial cell marker CD31
(Fig. 8B). However, some of the cadherin-9-positive cells also
expressed a2smooth muscle actin, a marker for smooth muscle
cells and activated fibroblasts (Fig. 8B). Because cadherin-9 was
not found on smooth muscle cells surrounding large blood vessels
and there were also cadherin-9-positive, but a2smooth muscle
actin- negative cells present, it seems possible that cadherin-9 is
also, but not only, expressed by activated fibroblasts. Some
cadherin-9-positive cells co-expressing the leukocyte marker
CD45 were also observed (Fig. 8B), but most of the CD45-positive
cells did not co-express cadherin-9. Thus, cadherin-9+ CD45+
cells might be immigrated fibrocytes, bone marrow-derived
circulating fibroblast precursors, which are known to express
CD45 [32].
Induction of cadherin-9 expression during
cyclosporin-A provoked EMT
A common clinical complication of the immunosuppressive agent
cyclosporin-A is a severe tubulo-interstitial fibrosis. One mecha-
nism in developing fibrosis is epithelial-mesenchymal transition of
renal tubular epithelial cells (EMT), which can also be induced in
vitro by cyclosporin-A [33]. Treatment of the renal epithelial cell
line TK 163 with cyclosporin-A induced a fibroblastic phenotype.
The cells lost their epithelial polygonal shape and gained an
elongated polygonal appearance (Fig. 9). This effect was slight at
4.2 mM cyclosporin-A and severe at 42 mM, but the latter
concentration was also toxic. Cyclosporin-A-treated TK 163 cells
clearly up-regulated vimentin and also started to express cadherin-
9 (Fig. 9). Treatment of TK 163 cells with TGF-b1, which is also
able to induce EMT but not transdifferentiation into myofibro-
blasts [34], did not induce cadherin-9 expression. Thus, cadherin-
9 up-regulation by cyclosporin-A might be a relatively late event
during EMT of renal tubular cells in renal fibrosis.
Figure 5. Localization of cadherin-9-positive cells in comparison to other cadherin expressing epithelial tubular cells. The micrographs show
double immunofluorescence staining of a normal human kidney with the cadherin-9 antiserum and monoclonal antibodies against E-cadherin (A),
Ksp-cadherin (B) and cadherin-6 (C), respectively. E-cadherin and Ksp-cadherin are marker molecules for distal tubules, whereas cadherin-6 is
specifically expressed in proximal tubules. However, no preferential distribution of cadherin-9 expressing cells was detected with either proximal or
distal tubular epithelial cells, nor any co-localization with the potential interaction partner cadherin-6 was observed. Bars: (A,C) 50 mm; (B) 100 mm.
doi:10.1371/journal.pone.0000657.g005
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Here, we identify the classical type II cadherin-9 as a specific and
reliable marker molecule for renal fibroblasts. In humans, but not
mice, cadherin-9 was found to be present throughout renal
development as well as in the adult organ. In renal cell carcinomas
its expression is restricted to the stromal compartment of the tumor.
Cadherin-9hasthetypicalhomophiliccelladhesionpropertiesofthe
classical cadherins, whereas heterophilic interactions with epithelial
cadherins of the kidney were not observed. Induction of EMT with
cyclosporin-A, which can trigger fibrosis in patients, led to an up-
regulation of cadherin-9 in converting renal epithelial cells.
Consistent with this observation, the percentage of cadherin-9-
expressing cells is clearly elevated in renal fibrotic tissue.
Figure 6. In renal cell carcinoma, cadherin-9 is exclusively expressed by the tumour stroma. (A, B) RT-PCR and Western blot analyses of ten or
eleven RCC cell lines, respectively, revealed that cadherin-9 was not expressed in any of the cell lines tested. In the Western blot analysis, the signal
detected in the TK 188 cell lysate served as a positive control. (C, D) The signals for cadherin-9 expression detected by RT-PCR or Western blot
analyses in renal tumor tissue were constantly much weaker compared to the normal kidney tissue adjacent to the tumor which appeared normal in
histology. (E) The immunohistochemical staining of RCC sections showed that cadherin-9 marked exclusively the tumor stroma. Bars, 100 mm.
Pictures of the immunoblots (B,D) were gamma-corrected.
doi:10.1371/journal.pone.0000657.g006
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can also be found in kidney, colon, small intestine, adipose tissues
and testes. Thus far, cadherin-9 expression had only been
described in human brain [29], in the limbic system of rats [35],
and in testes and CD4/CD8-double-positive thymocytes of mice
[36,37]. Thus, this is the first description of cadherin-9 in human
kidney, intestine and adipose tissue. In contrast to mice, cadherin-
9 is not expressed in the human thymus. Additionally, mice lose
cadherin-9 expression in the kidney during embryonic develop-
ment, whereas in the human kidney cadherin-9 is constantly
expressed during nephrogenesis and in the adult organ. Mice are
therefore not a suitable model to study renal cadherin-9 expression
after birth.
In the human kidney, cadherin-9 is exclusively expressed by
renal fibroblasts, as shown by the analysis of several renal cell lines
and tissues. Cadherin-9 is neither expressed by renal epithelial cells
nor by any of the renal cell carcinoma cell lines examined, which
were all of epithelial origin. The renal fibroblast cell line TK 188,
derived from a fibrotic kidney, is the only cadherin-9-positive cell
line found so far. Another renal fibroblast cell line, TK 173, which
was established from a non-fibrotic kidney, does not express
cadherin-9. TK 188 was found to synthesize higher amounts of
extracellular matrix and cytokines compared to TK 173 [38,39].
Thus, cadherin-9 might have a role in fibroblast activation, as
during development of renal fibrosis activated fibroblasts are
regarded as responsible for the massive deposition of extracellular
matrix, a hallmark of this pathology.
Thus far, there is no commonly-accepted marker molecule for
fibroblasts in the kidney. Cadherin-9 might be a good candidate to
fill this gap. Currently, the best-studied marker for renal fibroblasts
is FSP1, also known as S100A4, pEL98 or mts1 [4,40]. However,
the usefulness of FSP1 as a fibroblast marker is controversial [5].
Some investigators use FSP1 to differentiate fibroblasts from
macrophages in the fibrotic mouse kidney [41], while others have
reported FSP1 expression on monocytes and macrophages
[42,43]. One possible explanation for this discrepancy might be
species differences in the expression pattern of FSP1 [44]. In the
human kidney, the use of cadherin-9 as a fibroblast marker will
avoid the problems of FSP1, as it is a more restricted marker of
renal fibroblasts than FSP1. Compared to FSP1, cadherin-9
antibodies stain fewer cells in the human kidney. Importantly, it is
not expressed by any epithelial cells, while FSP1 can be found on
single tubular epithelial cells, which might be in the early process
of EMT [4]. Cadherin-9 was not expressed by renal tumor cells or
leukocytes, as clearly demonstrated in RCC tissues which showed
cadherin-9 expression only in the stromal compartment, but not in
tumor cells or leukocyte infiltrates. Also the tissue distribution of
cadherin-9, which is only expressed in a few organs, seems to be
more restricted than FSP1 [40]. Another advantage of cadherin-9,
compared to the cytosolic FSP1, is its surface expression which
Figure 7. Expression of cadherin-9 in renal fibrosis. Immunohistochemical staining of kidney sections of three fibrosis patients labeled with the
cadherin-9 antiserum are shown. The sections were counterstained with hematoxylin-eosin. Cadherin-9-positive cells as well as the total cell number
in selected view fields were counted by three independent individuals. Compared to normal kidney sections, a much higher number of cadherin-9
expressing cells could be detected in the fibrotic kidneys. Whereas in normal kidneys only 8.4%61.8 were positive for cadherin-9 expression, the
number of cadherin-9-positive cells in fibrotic kidneys was in the range of 25.7%67.8 and 42.5%61.1. Bars, 50 mm.
doi:10.1371/journal.pone.0000657.g007
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without permeabilization and thus killing the cells.
In a few cells, co-expression of cadherin-9 and a-smooth muscle
actin was found, which might represent activated fibroblasts, as
well as co-expression with CD45. The latter cell population could
be bone marrow-derived circulating fibrocytes [32], which
infiltrated the kidney. Summarizing our data on the different
marker molecules, we propose the following model of different
fibroblast subpopulations in the human kidney (Fig. 10): Cadherin-
9 is expressed by all fibroblast subpopulations of the human kidney
defined in this study. In contrast to other markers, it clearly
differentiates these fibroblasts from other renal cell types such as
epithelial cells, macrophages or smooth muscle cells. The
cadherin-9-positive cell population can be subdivided according
to co-expression of FSP1, CD45 and a-smooth muscle actin.
Fibrocytes co-express the common leukocyte antigen CD45 and
FSP1, whereas resident fibroblasts only co-express FSP1. During
EMT, FSP1 is up-regulated at an early stage [45], and it can
Figure 8. Cadherin-9 is a marker for renal fibroblasts. (A) Immunohistochemical staining of two consecutive kidney cryostat sections with antisera
against cadherin-9 and FSP1, a well-known renal fibroblast marker, showed that cadherin-9 positive cells also express FSP1. Staining of FSP1,
however, could be also observed in the cadherin-9 negative glomerulum and in some tubular cells. The inserts in the left panel are enlarged in the
right panel. (B) Cadherin-9 is not expressed by endothelial cells, as demonstrated by double immunofluorescence staining with the endothelial cell
marker CD31. But cadherin-9 expression partially overlaps with CD45 as well as with a-smooth muscle actin. Cells which express only a-smooth
muscle actin or CD45 are marked with an arrowhead, whereas cells which express only cadherin-9 with an arrow. Co-localization of a-smooth muscle
actin or CD45 with cadherin-9 are indicated by double arrows. The different magnifications in (A) and (B) are shown by different bars.
doi:10.1371/journal.pone.0000657.g008
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the epithelial layer of the tubules. Cadherin-9 appears later during
EMT and is undetectable in tubular cells. We found that cadherin-
9 expression could be induced by cyclosporin-A, but not by the
cytokine TGF-b. Cyclosporin-A, in contrast to TGF-b, not only
induces EMT but also myofibroblast transdifferentiation [33,34].
Calcineurin is the target of Cyclosporin-A in the cell. Thus, the
inducibility of cadherin-9 by Cyclosporin-A but not by TGF-
b suggests that cadherin-9 transcription might be regulated in an
calcineurin-dependent, but TGF-b- independent manner, compa-
rable to the recently described regulation of fibronectin gene
expression in murine renal fibroblasts [46]. Taking these data
together, we propose that cadherin-9 is a specific marker for renal
fibroblasts: the resident, mature and activated fibroblasts, the cells
late in the process of EMT as well as the fibroblastic cells in the
CD45+ pool (Fig. 10). However, cadherin-9 is not a general
fibroblast marker for all human tissues, since it is not expressed in
fibroblast-rich organs such as the skin (Fig. S3).
When human cadherin-9 was originally described, its function
was investigated in transfected mouse L-cell clones [29]. In our
present study, the interaction of cadherin-9 with catenins was
shown ex vivo in human kidney cell lysates. Its cellular localization
at the cell membrane and the ability to mediate cell-cell
interactions were demonstrated in the human kidney fibroblast
cell line TK 188, which mimics the natural situation of cadherin-9
in renal fibroblasts more closely than mouse L-cell transfectants.
However, only a minor, but significant effect of cadherin-9 on cell-
cell aggregation was observed, since knockdown of cadherin-9
decreased the ability to form cell aggregates by less than 15%. This
observation might be explained in two ways: Firstly, TK 188 cells
express other cell adhesion molecules, which could substitute for
the function of cadherin-9. Secondly, an additional function of
cadherin-9 seems to be likely, based on its distribution over the
entire cell surface and not only concentrated at cell-cell contacts.
However, an influence of cadherin-9 on cell migration, as
described for mesenchymal cadherins such as N-cadherin [47],
could not be found in transmigration and wound healing assays.
Thus, one might speculate on a function of cadherin-9 in cell
signaling, but strong evidence for such a role is still missing.
Shimoyama and coworkers [29] demonstrated in vitro the ability of
cadherin-9 to mediate not only homophilic, but also heterophilic
interactions. This was shown for cadherin-6 and cadherin-10,
which are the closest relatives of cadherin-9. Cadherin-10 is not
expressed in the adult human kidney (unpublished data), but
cadherin-6 was found to be expressed in proximal renal tubules.
However, double immunofluorescence staining revealed no
obvious co-localization of cadherin-6 and –9 at cell contacts
between fibroblasts and epithelial cells. Thus, at least in the human
kidney, cadherin-9 does not interact with cadherin-6 or cadherin-
10 in vivo, as they are either not expressed concomitantly (cadherin-
10) or not co-localized (cadherin-6).
As cadherin-9 is a specific marker for renal fibroblasts, the
question arises whether it might play a role in the process of kidney
fibrosis or whether it could be a suitable marker for the disease. In
human renal fibrotic tissues, the percentage of cadherin-9-positive
cells is clearly elevated. When and how cadherin-9 up-regulation
takes place during the course of the disease is difficult to answer,
since mice cannot be used as a model for renal cadherin-9
expression in fibrosis. During EMT, cadherin-9 seems to be up-
regulated at the later stages. However, whether the higher
Figure 9. Up-regulation of cadherin-9 expression during cyclosporin-A induced EMT. To induce a transition of renal epithelial cells into a spindle-
shaped mesenchymal cell type, the epithelial TK 163 cells were cultured for 48 hours in different concentrations (0, 4.2 and 42 mM) of cyclosporin-A
(CsA). EMT could be observed by phase contrast microscopy. Immunofluorescence staining revealed that without CsA no signals for cadherin-9 and
only weak signal for vimentin could be observed. Induction of EMT by CsA led to a strong up-regulation of both vimentin and cadherin-9 expression.
In contrast, incubation of TK 163 cells with 3 nM TGF-ß for two days does not lead to an induction of cadherin-9 expression. Bar, 50 mm.
doi:10.1371/journal.pone.0000657.g009
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originates from (I) epithelial cells undergoing EMT, (II) from the
activation and proliferation of renal fibroblasts, or (III) from
kidney infiltrating and differentiating fibrocytes cannot be
distinguished yet. According to the cadherin-9 expression pattern,
none of these three possibilities of renal fibrosis development can
be clearly favored, because our data only show an accumulation of
cadherin-9-positive cells in renal fibrosis, and cadherin-9 is
expressed by all fibroblast subtypes of the human kidney.
In conclusion, human cadherin-9 is a typical type II cadherin
which can mediate homotypic cell-cell interactions. In the kidney,
cadherin-9 is a specific marker for renal fibroblasts, but it is not
a general marker for fibroblasts in humans. Renal fibroblasts are
not a homogeneous cell population, and cadherin-9, together with
the marker molecules FSP1, CD45 and a-smooth muscle actin, is
an important tool to differentiate renal fibroblasts into fibrocytes,
cells undergoing EMT, resident fibroblasts and activated fibro-
blasts.
SUPPORTING INFORMATION
Figure S1 Cadherin-9 expression is higher in brain than in
kidney Cadherin-9 RT-PCR was performed and analyzed after
15, 20, 25, 30 and 35 cycles of amplification. Amplification of b-
actin served as an internal control of equal RNA input and quality.
The cadherin-9 amplification product appeared first in brain after
20 cycles, in kidney after 25 and in small intestine after 35 cycles.
Prostate tissue was negative for cadherin-9. Thus, the amount of
cadherin-9 mRNA in the different tissues decreases from brain to
kidney to small intestine and is not detectable in prostate. The
Figure 10. Model of antigen expression in different fibroblast pools, smooth muscle cells and monocytes in the human kidney. Together with
FSP1, a-smooth muscle actin (a sm actin) and CD45, cadherin-9 is a novel cell surface marker, which can be used to differentiate the depicted renal
fibroblast subpopulations from other renal cell types such as epithelial and endothelial cells, smooth muscle cells, monocytes or macrophages.
doi:10.1371/journal.pone.0000657.g010
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level of cadherin-9 mRNA in the different tissues.
Found at: doi:10.1371/journal.pone.0000657.s001 (2.08 MB TIF)
Figure S2 Cadherin-9 knockdown impairs the ability of renal
fibroblasts to aggregate Phase contrast pictures of TK 188 cells
treated with cadherin-9 or control siRNA were taken before
(0 min) and after 20 min of aggregation. At t=0 most cells were
single cells or very small aggregates (upper row). After 20 min the
cadherin-9 siRNA treated cells formed more and smaller
aggregates (lower left) compared to the control cells (lower right),
showing that the ability of renal fibroblasts to aggregate was
impaired by the knockdown of cadherin-9.
Found at: doi:10.1371/journal.pone.0000657.s002 (5.27 MB TIF)
Figure S3 Cadherin-9 is not expressed by human skin fibroblasts
Immunohistochemical staining of cadherin-9 in human skin
cryostat sections revealed no specific staining of any cells
compared to the negative control, in which the primary antibody
was omitted. Bars represent 50mm. (B) The primary human skin
fibroblasts SK 173 were analyzed for cadherin-9 expression by
RT-PCR. No cadherin-9 mRNA could be detected. b-actin
amplification served as an internal control, and as negative control
water instead of RNA was added.
Found at: doi:10.1371/journal.pone.0000657.s003 (6.63 MB TIF)
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